Clinical Trials Directory

Trials / Completed

CompletedNCT03106311

The Use of Quantitative Pregnancy Test in Amniotic Fluid as a Diagnostic Tool for Rupture of Fetal Membranes

Use of Beta Subunit of Human Chorionic Gonadotropin Assay as a Diagnostic Tool for Premature Rupture of Membranes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Cairo University · Academic / Other
Sex
Female
Age
17 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Two groups will be recruited. The first group are pregnant ladies that have unequivocal rupture of fetal membranes that is diagnosed by seeing the amniotic fluid leakage in the vagina. The second group are normal pregnant ladies without rupture of membranes. both groups will be tested by taking vaginal washing fluid. Quantitative and qualitative pregnancy tests will be measured in this fluid.

Detailed description

Beta subunit of human chorionic gonadotropin assay will be measured in the vaginal washing in two groups. The first group are pregnant women in the second or third trimester. These women have definite rupture of membranes diagnosed by visual leaking of the amniotic fluid from the cervix during speculum examination. The second group are pregnant women with intact membranes. Assessment of both the qualitative and quantitative beta subunit of human chorionic gonadotropin will be done

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTassessment of beta subunit of human chorionic gonadotropinVaginal washing fluid will be collected and sent for measurement of beta subunit of human chorionic gonadotropin

Timeline

Start date
2017-04-10
Primary completion
2017-06-29
Completion
2017-07-07
First posted
2017-04-10
Last updated
2017-07-11

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03106311. Inclusion in this directory is not an endorsement.